Co-Diagnostics, Inc.
CODX· Nasdaq
Co-Diagnostics, Inc.
- Last sale
- Oct 2, 2026 · +0.46%
- Market cap
- $6.85M
- 6.25M shares
- Filings
- 383
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $622,489 | reported | |
| FY 2024 | 2024-12-31 | $3,915,160 | reported | |
| FY 2023 | 2023-12-31 | $6,812,038 | reported | |
| FY 2022 | 2022-12-31 | $34,218,209 | reported | |
| FY 2021 | 2021-12-31 | $97,885,603 | reported | |
| FY 2020 | 2020-12-31 | $74,552,758 | reported | |
| FY 2019 | 2019-12-31 | $214,974 | reported | |
| FY 2018 | 2018-12-31 | $39,911 | reported | |
| FY 2017 | 2017-12-31 | $7,662 | reported |
Co-Diagnostics, Inc. · CIK 1692415 · Engraved from SEC EDGAR
